When Wall Street suffered huge losses after business activity was disrupted across the country due to the COVID-19 outbreak, one industry that
Abbott Laboratories
-(ABT)
XNYS:ABT
Abbott Laboratories (NYSE: ABT) Q4 2019 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q4 2019 Earnings Conference Call Jan. 22, 2020 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing and Acquisitions
Abbott Laboratories (ABT) reports in-line earnings for Q4; guides FY20
Abbott Laboratories (NYSE: ABT) reported a marked increase in fourth-quarter earnings as the drugmaker's strong product portfolio boosted sales in the key
Abbott Laboratories (ABT) reports in-line earnings for Q3; sales miss view
Abbott Laboratories' (NYSE: ABT) third quarter 2019 earnings came in line with the market's projections, while sales missed the expectations. The pharma
Abbott Laboratories: Solid product line expected to boost Q3 results
There are few pharmaceutical companies as solid as Abbott Laboratories (NYSE: ABT). Thanks to the two major acquisitions it made a couple
Abbott Laboratories net earnings soar in first quarter
Abbott Laboratories (ABT) announced its first-quarter 2019 earnings results on Wednesday, April 17, before the opening bell. In the three-month period, worldwide
Earnings preview: Medical devices to drive Abbott Q1 results
Abbott Laboratories (NYSE: ABT) is scheduled to report its earnings results for the first quarter of 2019 on Wednesday before the market
Calendar: Earnings of Bank of America, IBM, United Airlines, PepsiCo on queue
Bank of America, IBM, United Airlines, PepsiCo and more earnings are scheduled for the week between April 15 and 19. Check out
Axsome Therapeutics stock climbs to 34-month high
After the slump on weak quarterly results, investors turned positive on Axsome Therapeutics (AXSM) stock, which climbed to the 34-month high of
Avid Bioservices stock jumps after Q3 loss narrows on higher revenues
Avid Bioservices (CDMO) reported a narrower net loss for the third quarter of 2019, aided by a sharp increase in revenues and
Abbott Laboratories swings to profit in Q4, beats estimates
Abbott Laboratories (ABT) swung to a profit in the fourth quarter from a loss last year, helped by a decline in tax
Abbott earnings preview: Pharma, medical devices to drive Q4 results
Healthcare giant Abbott Laboratories (ABT) is expected to post upbeat results for the fourth quarter on Wednesday before the bell, despite the